{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260825415559/en/Ivonescimab-Plus-Chemotherapy-Global-Phase-III-HARMONi-Primary-Analysis-Results-Published-in-The-Lancet-Oncology", "message": "News view counter 900719 successfully enlarged"}